Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury
- PMID: 26547005
- DOI: 10.1016/j.wneu.2015.10.066
Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury
Abstract
Objective: Biomarkers ubiquitin C-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) may help detect brain injury, assess its severity, and improve outcome prediction. This study aimed to evaluate the prognostic value of these biomarkers during the first days after brain injury.
Methods: Serum UCH-L1 and GFAP were measured in 324 patients with traumatic brain injury (TBI) enrolled in a prospective study. The outcome was assessed using the Glasgow Outcome Scale (GOS) or the extended version, Glasgow Outcome Scale-Extended (GOSE).
Results: Patients with full recovery had lower UCH-L1 concentrations on the second day and patients with favorable outcome had lower UCH-L1 concentrations during the first 2 days compared with patients with incomplete recovery and unfavorable outcome. Patients with full recovery and favorable outcome had significantly lower GFAP concentrations in the first 2 days than patients with incomplete recovery or unfavorable outcome. There was a strong negative correlation between outcome and UCH-L1 in the first 3 days and GFAP levels in the first 2 days. On arrival, both UCH-L1 and GFAP distinguished patients with GOS score 1-3 from patients with GOS score 4-5, but not patients with GOSE score 8 from patients with GOSE score 1-7. For UCH-L1 and GFAP to predict unfavorable outcome (GOS score ≤ 3), the area under the receiver operating characteristic curve was 0.727, and 0.723, respectively. Neither UCHL-1 nor GFAP was independently able to predict the outcome when age, worst Glasgow Coma Scale score, pupil reactivity, Injury Severity Score, and Marshall score were added into the multivariate logistic regression model.
Conclusions: GFAP and UCH-L1 are significantly associated with outcome, but they do not add predictive power to commonly used prognostic variables in a population of patients with TBI of varying severities.
Keywords: Biomarkers; GFAP; Outcome; Traumatic brain injury; UCH-L1.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.Neurosurgery. 2016 Sep;79(3):456-64. doi: 10.1227/NEU.0000000000001226. Neurosurgery. 2016. PMID: 26963330
-
Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.J Neurotrauma. 2014 Jan 1;31(1):19-25. doi: 10.1089/neu.2013.3040. Epub 2013 Oct 9. J Neurotrauma. 2014. PMID: 23865516 Free PMC article.
-
Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.Crit Care. 2011 Jun 24;15(3):R156. doi: 10.1186/cc10286. Crit Care. 2011. PMID: 21702960 Free PMC article.
-
Serum ubiquitin C-terminal hydrolase L1 as a biomarker for traumatic brain injury: a systematic review and meta-analysis.Am J Emerg Med. 2015 Sep;33(9):1191-6. doi: 10.1016/j.ajem.2015.05.023. Epub 2015 May 29. Am J Emerg Med. 2015. PMID: 26087705 Review.
-
A Narrative Review of Existing and Developing Biomarkers in Acute Traumatic Brain Injury for Potential Military Deployed Use.Mil Med. 2024 May 18;189(5-6):e1374-e1380. doi: 10.1093/milmed/usad433. Mil Med. 2024. PMID: 37995274 Review.
Cited by
-
Developing Biomarkers of Mild Traumatic Brain Injury: Promise and Progress of CNS-Derived Exosomes.Front Neurol. 2022 Feb 10;12:698206. doi: 10.3389/fneur.2021.698206. eCollection 2021. Front Neurol. 2022. PMID: 35222223 Free PMC article. Review.
-
An update on diagnostic and prognostic biomarkers for traumatic brain injury.Expert Rev Mol Diagn. 2018 Feb;18(2):165-180. doi: 10.1080/14737159.2018.1428089. Epub 2018 Jan 23. Expert Rev Mol Diagn. 2018. PMID: 29338452 Free PMC article. Review.
-
A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.J Neurotrauma. 2019 Oct 15;36(20):2850-2862. doi: 10.1089/neu.2019.6375. Epub 2019 Jun 19. J Neurotrauma. 2019. PMID: 31072225 Free PMC article.
-
HIV-1 TAT protein enhances sensitization to methamphetamine by affecting dopaminergic function.Brain Behav Immun. 2017 Oct;65:210-221. doi: 10.1016/j.bbi.2017.05.004. Epub 2017 May 8. Brain Behav Immun. 2017. PMID: 28495611 Free PMC article.
-
Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients.J Neurotrauma. 2021 Jan 1;38(1):1-43. doi: 10.1089/neu.2020.7332. Epub 2020 Nov 11. J Neurotrauma. 2021. PMID: 33115334 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous